{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-26-000020","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2026-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.539696+00:00","generated_at":"2026-05-16T01:56:46.460654+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Charles River Labs Q4 revenue $994M, GAAP loss $5.62; sees 2026 non-GAAP EPS $10.70-$11.20","bullets":["Q4 GAAP loss per share $(5.62) from $994.2M revenue (-0.8% YoY); non-GAAP EPS $2.39 (-10.2%).","FY2025 revenue $4.02B (-0.9%); GAAP loss $(2.91)/share; non-GAAP EPS $10.28 (-0.4% vs $10.32).","DSA organic revenue -3.3% in Q4; CEO cites robust DSA net bookings and cautious optimism for demand recovery.","2026 organic revenue guidance (1.0)% to flat; non-GAAP EPS $10.70-$11.20 implies 4-9% growth.","Recorded $211M intangible and $165M goodwill impairments in Biologics Solutions (Manufacturing segment)."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-26-000020","json":"https://secwatch.observer/filing/0001100682-26-000020.json","markdown":"https://secwatch.observer/filing/0001100682-26-000020.md","text":"https://secwatch.observer/filing/0001100682-26-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000020/0001100682-26-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000020/crl-20260218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:56:46.460654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}